HUMMINGBUD Trademark
Serial Number: 79396942 • Registration: 7699974
HUMMINGBUD is a trademark filed by
Rachel Holdaway
on April 25, 2024. The trademark is classified under Class 10 (Medical Apparatus).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Norman R. Van Treeck Pasadena Legal Group
PO Box 3399
Landers, CA 92285
United States
Trademark Details
Filing Date
April 25, 2024
Registration Date
February 25, 2025
Published for Opposition
January 7, 2025
Goods & Services
Electro-stimulation apparatus for use in therapeutic treatment, namely, for nerves
Filing History
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 22, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 5, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 5, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 27, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 4, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 4, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 26, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 25, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 10, 2024 CNSA
REFUSAL PROCESSED BY IB
Dec 7, 2024 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 6, 2024 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 15, 2024 RFCS
REFUSAL PROCESSED BY MPU
Nov 14, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 9, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 8, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 8, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 10, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 10, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 6, 2024 REPR